<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" 

"journalpublishing3.dtd">

<article 
article-type="research-article"
dtd-version="3.0" xml:lang="en" 
xmlns:mml="http://www.w3.org/1998/Math/MathML"
xmlns:xlink="http://www.w3.org/1999/xlink" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
>

<front>

<journal-meta>

  <journal-id journal-id-type="publisher">32</journal-id>
  <issn>24765236</issn>

  <publisher>

	<publisher-name>Iranian Society of Physiology and Pharmacology</publisher-name>
  </publisher>

</journal-meta>



<article-meta>

  <article-id pub-id-type="publisher-id">2483</article-id>

  <article-categories>
	<subj-group>
	  <subject>Others</subject>

	</subj-group>
  </article-categories>

  <title-group>
	<article-title>Complex of zinc (II) methylthiosemicarbazone
induces cytotoxicity, antiproliferative, and apoptosis
effects in human K562 leukemia</article-title>

  </title-group>

  


  <contrib-group>

  
	<contrib contrib-type="author">

	  <name>

		<surname>namvar aghdash</surname>
		<given-names>simin</given-names>
	  </name> 

	  <xref ref-type="aff">
		<sup>
		  <italic>b</italic>

		</sup>
	  </xref>

	</contrib> 
	

	<contrib contrib-type="author">

	  <name>

		<surname>Mahdavi</surname>
		<given-names>Majid</given-names>
	  </name> 

	  <xref ref-type="aff">
		<sup>
		  <italic>c</italic>

		</sup>
	  </xref>

	</contrib> 
	

	<contrib contrib-type="author">

	  <name>

		<surname>Foroughi</surname>
		<given-names>Golsa</given-names>
	  </name> 

	  <xref ref-type="aff">
		<sup>
		  <italic>d</italic>

		</sup>
	  </xref>

	</contrib> 
	

  </contrib-group>

  
			<aff>

			
	<sup>
	  <italic>b</italic>

	</sup>Department of Biology, Faculty of Basic Sciences, Azarbaijan Shahid Madani University, Tabriz, Iran 
  
 
	<sup>
	  <italic>c</italic>

	</sup>Institute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran 
  
 
	<sup>
	  <italic>d</italic>

	</sup>Department of Biology, Faculty of Basic Sciences, Azarbaijan Shahid Madani University, Tabriz, Iran 
  
 
	</aff>
 
 
  


  <pub-date pub-type="pub">

	<day>1</day>
	<month>3</month>

	<year>2026</year>

  </pub-date>

  <volume>30</volume>

  <issue>1</issue>

  <fpage>1</fpage>

  <lpage>9</lpage>

  
			  <history>

				<date date-type="received">

				  <day>01</day>
				  <month>02</month>
				  <year>2025</year>
				</date>

			  </history>

		
			  <history>

				<date date-type="accepted">

				  <day>07</day>
				  <month>09</month>
				  <year>2025</year>
				</date>

			  </history>

		
</article-meta>

</front>



<body>

Introduction: Methylthiosemicarbazones (MTSCs) are compounds with various biological properties. Some studies have shown that their metal complexes have potential cytotoxic effects on numerous cancers. In this study, the effects of zinc (II)-methylthiosemicarbazone complex (Zn-MTC) on the human chronic myelogenous leukemia K562 cell line were evaluated.
Methods: In this experimental study, K562 cells were treated with different doses of Zn-MTC for 24, 48, and 72 hours. We investigated whether this compound could induce cytotoxicity and apoptosis in K562 cells using the MTT assay, fluorescence microscopy, and flow cytometry.
Results: Our findings indicated that Zn-MTC inhibited the growth of K562 cells and induced apoptosis in a time- and dose-dependent manner. The IC50 of the complex was 100 &#181;M after 72 hours of incubation. Morphological changes and sub-G1 cell cycle arrest confirmed the induction of apoptosis in K562 cells treated with the IC50 concentration of this compound.
Conclusion: Given its antiproliferative and apoptosis-inducing effects, Zn-MTC can be proposed for further pharmaceutical evaluation in the treatment of chronic myeloid leukemia (CML) in the future.
</body>

</article>


  <article-id pub-id-type="publisher-id">2540</article-id>

  <article-categories>
	<subj-group>
	  <subject>Neurophysiology/Pharmacology</subject>

	</subj-group>
  </article-categories>

  <title-group>
	<article-title>Gender disparities, environmental pollutants,
genetic and epigenetics in autism spectrum disorder:
revealing the links</article-title>

  </title-group>

  


  <contrib-group>

  
	<contrib contrib-type="author">

	  <name>

		<surname>A. Ghanimi</surname>
		<given-names>Hussein</given-names>
	  </name> 

	  <xref ref-type="aff">
		<sup>
		  <italic>e</italic>

		</sup>
	  </xref>

	</contrib> 
	

	<contrib contrib-type="author">

	  <name>

		<surname>H. Maad</surname>
		<given-names>Abdullah</given-names>
	  </name> 

	  <xref ref-type="aff">
		<sup>
		  <italic>f</italic>

		</sup>
	  </xref>

	</contrib> 
	

	<contrib contrib-type="author">

	  <name>

		<surname>Omar Khudhur</surname>
		<given-names>Zhikal</given-names>
	  </name> 

	  <xref ref-type="aff">
		<sup>
		  <italic>g</italic>

		</sup>
	  </xref>

	</contrib> 
	

	<contrib contrib-type="author">

	  <name>

		<surname>Karimian</surname>
		<given-names>Aida</given-names>
	  </name> 

	  <xref ref-type="aff">
		<sup>
		  <italic>h</italic>

		</sup>
	  </xref>

	</contrib> 
	

	<contrib contrib-type="author">

	  <name>

		<surname>Nahumi</surname>
		<given-names>Aida</given-names>
	  </name> 

	  <xref ref-type="aff">
		<sup>
		  <italic>i</italic>

		</sup>
	  </xref>

	</contrib> 
	

	<contrib contrib-type="author">

	  <name>

		<surname>Asadi</surname>
		<given-names>Asadollah</given-names>
	  </name> 

	  <xref ref-type="aff">
		<sup>
		  <italic>j</italic>

		</sup>
	  </xref>

	</contrib> 
	

	<contrib contrib-type="author">

	  <name>

		<surname>Taheri</surname>
		<given-names>Hasan</given-names>
	  </name> 

	  <xref ref-type="aff">
		<sup>
		  <italic>k</italic>

		</sup>
	  </xref>

	</contrib> 
	

	<contrib contrib-type="author">

	  <name>

		<surname>Abdolmaleki</surname>
		<given-names>Arash</given-names>
	  </name> 

	  <xref ref-type="aff">
		<sup>
		  <italic>l</italic>

		</sup>
	  </xref>

	</contrib> 
	

  </contrib-group>

  
			<aff>

			
	<sup>
	  <italic>e</italic>

	</sup>1.College of Nursing, University of Al-Ameed, Karbala, Iraq 
  
 
	<sup>
	  <italic>f</italic>

	</sup>Department of pharmaceutics, College of pharmacy, University of Al-Ameed, Karbala, Iraq 
  
 
	<sup>
	  <italic>g</italic>

	</sup>Biology Education Department, Tishk International University, Erbil, Iraq 
  
 
	<sup>
	  <italic>h</italic>

	</sup>Department of Biology, Faculty of Science, University of Mohaghegh Ardabili, Ardabil, Iran 
  
 
	<sup>
	  <italic>i</italic>

	</sup>Department of Biology, Faculty of Science, University of Mohaghegh Ardabili, Ardabil, Iran 
  
 
	<sup>
	  <italic>j</italic>

	</sup>Department of Biology, Faculty of Science, University of Mohaghegh Ardabili, Ardabil, Iran 
  
 
	<sup>
	  <italic>k</italic>

	</sup>Faculty of Psychology and Educational Sciences, Allameh Tabataba’i University, Tehran, Iran 
  
 
	<sup>
	  <italic>l</italic>

	</sup>Department of Biophysics, Faculty of Advanced Technologies, University of Mohaghegh Ardabili, Namin, Iran 
  
 
	</aff>
 
 
  


  <pub-date pub-type="pub">

	<day>1</day>
	<month>3</month>

	<year>2026</year>

  </pub-date>

  <volume>30</volume>

  <issue>1</issue>

  <fpage>10</fpage>

  <lpage>21</lpage>

  
			  <history>

				<date date-type="received">

				  <day>15</day>
				  <month>05</month>
				  <year>2025</year>
				</date>

			  </history>

		
			  <history>

				<date date-type="accepted">

				  <day>28</day>
				  <month>09</month>
				  <year>2025</year>
				</date>

			  </history>

		
</article-meta>

</front>



<body>

Autism Spectrum Disorder (ASD) is a complex neurodevelopmental disorder characterized by deficits in social interaction, communication challenges, and repetitive behaviors. Its etiology is multifactorial, involving interactions among genetic, epigenetic, and environmental factors. Recent studies have revealed that environmental pollutants, immune dysregulation, mitochondrial dysfunction, oxidative stress, and epigenetic alterations play significant roles in the development of ASD. Exposure to environmental toxins such as heavy metals and air pollutants has been linked to an increased risk of ASD, primarily by inducing oxidative stress, neuroinflammation, and neurotoxicity. Immune dysregulation, marked by abnormal immune responses, may also contribute to neurodevelopmental alterations observed in ASD. Mitochondrial dysfunction, resulting in impaired energy metabolism and elevated oxidative stress, is frequently reported in individuals with ASD. In addition, epigenetic mechanisms such as DNA methylation and histone modifications are crucial for regulating gene expression and can be influenced by environmental exposures. Individuals with ASD exhibit abnormal epigenetic patterns, indicating that environmental factors can influence gene function without modifying the genetic code. The higher prevalence of ASD in males indicates potential sex-specific susceptibilities and points to a complex gene&#8211;environment interaction. While genetic predisposition is a major factor, environmental influences may intensify or reduce the risk. Understanding these interconnected mechanisms is vital for developing improved diagnostic tools, early interventions, and effective therapies. Future research should aim to identify specific biomarkers and molecular targets, enabling personalized approaches to ASD management. A deeper understanding of these mechanisms offers promising pathways for prevention, early detection, and treatment of ASD.
</body>

</article>


  <article-id pub-id-type="publisher-id">2460</article-id>

  <article-categories>
	<subj-group>
	  <subject>Clinical Physiology/Pharmacology</subject>

	</subj-group>
  </article-categories>

  <title-group>
	<article-title>A systematic review and bioinformatics analysis on
DNA methylation status in age-related hearing loss</article-title>

  </title-group>

  


  <contrib-group>

  
	<contrib contrib-type="author">

	  <name>

		<surname>Khoshsirat</surname>
		<given-names>Shahrokh</given-names>
	  </name> 

	  <xref ref-type="aff">
		<sup>
		  <italic>m</italic>

		</sup>
	  </xref>

	</contrib> 
	

	<contrib contrib-type="author">

	  <name>

		<surname>bazgir</surname>
		<given-names>narges</given-names>
	  </name> 

	  <xref ref-type="aff">
		<sup>
		  <italic>n</italic>

		</sup>
	  </xref>

	</contrib> 
	

	<contrib contrib-type="author">

	  <name>

		<surname>mosleh</surname>
		<given-names>haideh</given-names>
	  </name> 

	  <xref ref-type="aff">
		<sup>
		  <italic>o</italic>

		</sup>
	  </xref>

	</contrib> 
	

	<contrib contrib-type="author">

	  <name>

		<surname>Raissi</surname>
		<given-names>Simin</given-names>
	  </name> 

	  <xref ref-type="aff">
		<sup>
		  <italic>p</italic>

		</sup>
	  </xref>

	</contrib> 
	

	<contrib contrib-type="author">

	  <name>

		<surname>amanzadeh jajin</surname>
		<given-names>elanaz</given-names>
	  </name> 

	  <xref ref-type="aff">
		<sup>
		  <italic></italic>

		</sup>
	  </xref>

	</contrib> 
	

	<contrib contrib-type="author">

	  <name>

		<surname>Niknazar</surname>
		<given-names>Somayeh</given-names>
	  </name> 

	  <xref ref-type="aff">
		<sup>
		  <italic></italic>

		</sup>
	  </xref>

	</contrib> 
	

  </contrib-group>

  
			<aff>

			
	<sup>
	  <italic>m</italic>

	</sup>Hearing Disorders Research Center, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran 
  
 
	<sup>
	  <italic>n</italic>

	</sup>Hearing Disorders Research Center, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran 
  
 
	<sup>
	  <italic>o</italic>

	</sup>Department of Otolaryngology, Head and Neck Surgery, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran 
  
 
	<sup>
	  <italic>p</italic>

	</sup>Student Research Cmmittee, Shahid Beheshti University of Medical Sciences, Tehran, Iran 
  
 
	<sup>
	  <italic></italic>

	</sup>Functional Neurosurgery Research Center, Research Institute of Functional Neurosurgery, Shohada Tajrish Neurosurgical Center of Excellence, Shahid Beheshti University of Medical Sciences, Tehran, Iran 
  
 
	<sup>
	  <italic></italic>

	</sup>Functional Neurosurgery Research Center, Research Institute of Functional Neurosurgery, Shohada Tajrish Neurosurgical Center of Excellence, Shahid Beheshti University of Medical Sciences, Tehran, Iran 
  
 
	</aff>
 
 
  


  <pub-date pub-type="pub">

	<day>1</day>
	<month>3</month>

	<year>2026</year>

  </pub-date>

  <volume>30</volume>

  <issue>1</issue>

  <fpage>22</fpage>

  <lpage>37</lpage>

  
			  <history>

				<date date-type="received">

				  <day>05</day>
				  <month>12</month>
				  <year>2024</year>
				</date>

			  </history>

		
			  <history>

				<date date-type="accepted">

				  <day>19</day>
				  <month>10</month>
				  <year>2025</year>
				</date>

			  </history>

		
</article-meta>

</front>



<body>

Many individuals experience age-related hearing loss (ARHL), yet it frequently goes unnoticed. Its prevalence increases two-fold with every ten years of age. Epigenetics is linked to heritable modifications in gene activity that are not caused by alterations in DNA sequence. In this review, our goal is to assess the variety of DNA methylation in individuals with ARHL. Methods: We conducted a systematic review of studies that report changes in DNA methylation among patients with presbycusis. The study used the PECO framework to establish the eligibility criteria for patients with ARHL. A search was performed on Embase, PubMed, Scopus, Google Scholar, and ScienceDirect. Furthermore, a bioinformatics analysis was performed. Results: A total of seven studies were reviewed. Eighteen genes including P2RX2, KCNQ5, SOCS3, ERBB3, TCF25, POLE, ESPN, TNFRSF25, FGFR1, CDH23, SLC26A4, MEF2D, LCK, ACP6, ALG10, DUSPK4, C21orf58 and GBX2 were differentially methylated. To contextualize these in ARHL pathways, we integrated them with 136 ARHL-associated genes for PPI network analysis, identifying nine hub genes. Then we performed the overlap analysis using R to identify intersections between 18 methylated genes and the hub genes. After conducting enrichment analysis for hub genes, differentially methylated genes, and intersected genes, it was revealed that ERBB3, P2RX2, and FGFR1 were involved in the calcium signaling pathway. Besides, the overlap of methylated genes with ARHL hubs identifies SLC26A4, ERBB3, and CDH23 as key candidates. Conclusion: This review demonstrated that DNA methylation could cause the development of ARHL. Changes in gene methylation can disrupt the calcium signaling pathway, potentially leading to presbycusis.
</body>

</article>


  <article-id pub-id-type="publisher-id">2499</article-id>

  <article-categories>
	<subj-group>
	  <subject>Clinical Physiology/Pharmacology</subject>

	</subj-group>
  </article-categories>

  <title-group>
	<article-title>Translation and psychometric evaluation of the
persian version of the treatment satisfaction
with medicines questionnaire (SATMED-Q) in
chronically-ill patients</article-title>

  </title-group>

  


  <contrib-group>

  
	<contrib contrib-type="author">

	  <name>

		<surname>Khatib</surname>
		<given-names>Ali</given-names>
	  </name> 

	  <xref ref-type="aff">
		<sup>
		  <italic></italic>

		</sup>
	  </xref>

	</contrib> 
	

	<contrib contrib-type="author">

	  <name>

		<surname>Barkhordari-Sharifabad</surname>
		<given-names>Maasoumeh</given-names>
	  </name> 

	  <xref ref-type="aff">
		<sup>
		  <italic></italic>

		</sup>
	  </xref>

	</contrib> 
	

	<contrib contrib-type="author">

	  <name>

		<surname>Pazhavand</surname>
		<given-names>Mohammad Mahdi</given-names>
	  </name> 

	  <xref ref-type="aff">
		<sup>
		  <italic></italic>

		</sup>
	  </xref>

	</contrib> 
	

  </contrib-group>

  
			<aff>

			
	<sup>
	  <italic></italic>

	</sup>Department of Nursing, Faculty of Nursing and Midwifery, Neyshabur University of Medical Sciences, Neyshabur, Iran 
  
 
	<sup>
	  <italic></italic>

	</sup>Department of Nursing, YMS. C., Islamic Azad University, Yazd, Iran 
  
 
	<sup>
	  <italic></italic>

	</sup>Department of Medical Ethics, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran 
  
 
	</aff>
 
 
  


  <pub-date pub-type="pub">

	<day>1</day>
	<month>3</month>

	<year>2026</year>

  </pub-date>

  <volume>30</volume>

  <issue>1</issue>

  <fpage>38</fpage>

  <lpage>47</lpage>

  
			  <history>

				<date date-type="received">

				  <day>16</day>
				  <month>02</month>
				  <year>2025</year>
				</date>

			  </history>

		
			  <history>

				<date date-type="accepted">

				  <day>07</day>
				  <month>09</month>
				  <year>2025</year>
				</date>

			  </history>

		
</article-meta>

</front>



<body>

Introduction:&#160;It is helpful to know the rate of satisfaction with treatment for predicting treatment adherence and compliance with medical advice. Thus, measuring this parameter is important both in daily clinical care and in biomedical research. Due to the unavailability of an instrument to evaluate treatment satisfaction with medicines in Persian, this study dealt with translating and psychometrically evaluating the Persian version of the Treatment Satisfaction with Medicines Questionnaire (SATMED-Q) in chronically ill patients.
Methods: This descriptive cross-sectional study was performed in two stages: translation and psychometric evaluation. After obtaining permission from the developer of the questionnaire, the process of translation was carried out based on Wild&#8217;s model (2005). Face validity (20 chronically-ill patients), qualitative content validity (10 experts), and construct validity including confirmatory factor analysis (225 chronically ill patients), were employed to establish the validity of the questionnaire. Further, the reliability of the instrument was established by determining the internal consistency and intra-class correlation (51 chronically ill patients). The data were analyzed using SPSS23 and LISREL8.5.
Results: To assess face and content validity, the questionnaire items underwent modifications based on feedback from patients and experts. According to confirmatory factor analysis, the fit index values demonstrated an appropriate alignment between the model and data. The subscales&#8217; Cronbach&#8217;s &#945; coefficients ranged from 0.905 to 0.985, while the entire questionnaire&#8217;s Cronbach&#8217;s &#945; coefficient was 0.875. Additionally, the test-retest reliability, as measured via the intra-class correlation coefficient, was determined to be 0.739 over two weeks.
Conclusion: The Persian version of the SATMED-Q has appropriate face, content, construct, and criterion-referenced validity as well as reliability for assessing treatment satisfaction with medicines in chronically ill patients. It is also advisable to use it in clinical studies, clinical settings, education, and management.
</body>

</article>


  <article-id pub-id-type="publisher-id">2476</article-id>

  <article-categories>
	<subj-group>
	  <subject>Others</subject>

	</subj-group>
  </article-categories>

  <title-group>
	<article-title>Effect of upper cervical mobilization on activation
of sensory areas of the brain: an fMRI study in
migraine patients</article-title>

  </title-group>

  


  <contrib-group>

  
	<contrib contrib-type="author">

	  <name>

		<surname>Farahmand Farzaneh</surname>
		<given-names>Jaleh</given-names>
	  </name> 

	  <xref ref-type="aff">
		<sup>
		  <italic></italic>

		</sup>
	  </xref>

	</contrib> 
	

	<contrib contrib-type="author">

	  <name>

		<surname>Bahrpeyma</surname>
		<given-names>Farid</given-names>
	  </name> 

	  <xref ref-type="aff">
		<sup>
		  <italic></italic>

		</sup>
	  </xref>

	</contrib> 
	

	<contrib contrib-type="author">

	  <name>

		<surname>Lotfi</surname>
		<given-names>Mehrzad</given-names>
	  </name> 

	  <xref ref-type="aff">
		<sup>
		  <italic></italic>

		</sup>
	  </xref>

	</contrib> 
	

	<contrib contrib-type="author">

	  <name>

		<surname>Masjoodi</surname>
		<given-names>Sadegh</given-names>
	  </name> 

	  <xref ref-type="aff">
		<sup>
		  <italic></italic>

		</sup>
	  </xref>

	</contrib> 
	

  </contrib-group>

  
			<aff>

			
	<sup>
	  <italic></italic>

	</sup>Department of Physiotherapy, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran 
  
 
	<sup>
	  <italic></italic>

	</sup>Department of Physiotherapy, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran 
  
 
	<sup>
	  <italic></italic>

	</sup>Department of Radiology, School of Medicine, Medical Imaging Research Center, Shiraz University of Medicine Sciences, Shiraz, Iran 
  
 
	<sup>
	  <italic></italic>

	</sup>Shiraz Neuroscience Research Center, Shiraz University of Medicine Sciences, Shiraz, Iran 
  
 
	</aff>
 
 
  


  <pub-date pub-type="pub">

	<day>1</day>
	<month>3</month>

	<year>2026</year>

  </pub-date>

  <volume>30</volume>

  <issue>1</issue>

  <fpage>48</fpage>

  <lpage>69</lpage>

  
			  <history>

				<date date-type="received">

				  <day>29</day>
				  <month>01</month>
				  <year>2025</year>
				</date>

			  </history>

		
			  <history>

				<date date-type="accepted">

				  <day>01</day>
				  <month>07</month>
				  <year>2025</year>
				</date>

			  </history>

		
</article-meta>

</front>



<body>

Introduction: Given the sensory network dysfunction observed in migraine, this study aimed to investigate the effects of upper cervical mobilization on sensory brain activation using functional magnetic resonance imaging (fMRI) during trigeminal pain stimulation.
Methods: Thirty-nine migraine patients were randomized into an intervention group (n = 22), receiving upper cervical mobilization, or a sham group (n = 17). All participants underwent fMRI scans before and after ten sessions. Trigeminal pain was induced using intranasal ammonia, and pain intensity was rated using the Visual Analog Scale (VAS). Brain activity was analyzed in sensory-related regions, including the primary somatosensory cortex (S1), angular and supramarginal gyri, superior parietal lobule (SPL), and thalamus. Outcomes included mean Z-score (statistical strength of brain activation relative to background noise), percent signal change (PSC; percentage change in regional BOLD signal relative to baseline), voxel count (activation volume), and contrast of parameter estimates (COPE; amplitude of the trigeminal pain&#8211;related BOLD response). using ANCOVA (adjusted for baseline), with effect sizes reported using epsilon squared (&#949;&#178;) or partial eta squared (&#951;&#178;).
Results: The mobilization group showed a greater pain reduction (Cohen&#8217;s d &#8776; 2.60) than the sham group (r &#8776; 0.64). Voxel count in bilateral supramarginal gyri decreased significantly (&#951;&#178; &#8776; 0.21, 0.11), as did BOLD signal in right SPL (&#949;&#178; &#8776; 0.08). Right S1 activation deviation correlated with pain reduction (r = 0.69). Pain reduction also correlated negatively with thalamic PSC (&#961; &#8776; &#8211;0.36) and right angular gyrus COPD (&#961; &#8776; &#8211;0.35).
Conclusion: Upper cervical mobilization significantly reduced migraine pain and modulated activity in brain regions associated with pain and sensorimotor processing, suggesting a potential neurofunctional mechanism of action.
</body>

</article>


  <article-id pub-id-type="publisher-id">2484</article-id>

  <article-categories>
	<subj-group>
	  <subject>Others</subject>

	</subj-group>
  </article-categories>

  <title-group>
	<article-title>Comparison of the effects of platelet-rich plasma
and erythropoietin on nephropathy and hepatopathy
in streptozotocin-induced diabetic rats: a
biochemical, oxidative stress, and histopathological
study</article-title>

  </title-group>

  


  <contrib-group>

  
	<contrib contrib-type="author">

	  <name>

		<surname>Ahooghalandari</surname>
		<given-names>Seyedeh Bahar</given-names>
	  </name> 

	  <xref ref-type="aff">
		<sup>
		  <italic></italic>

		</sup>
	  </xref>

	</contrib> 
	

	<contrib contrib-type="author">

	  <name>

		<surname>Jalali</surname>
		<given-names>Seyedeh Missagh</given-names>
	  </name> 

	  <xref ref-type="aff">
		<sup>
		  <italic></italic>

		</sup>
	  </xref>

	</contrib> 
	

	<contrib contrib-type="author">

	  <name>

		<surname>Jamshidian</surname>
		<given-names>Javad</given-names>
	  </name> 

	  <xref ref-type="aff">
		<sup>
		  <italic></italic>

		</sup>
	  </xref>

	</contrib> 
	

	<contrib contrib-type="author">

	  <name>

		<surname>Rezaie</surname>
		<given-names>Annahita</given-names>
	  </name> 

	  <xref ref-type="aff">
		<sup>
		  <italic></italic>

		</sup>
	  </xref>

	</contrib> 
	

  </contrib-group>

  
			<aff>

			
	<sup>
	  <italic></italic>

	</sup>Department of Clinical sciences, Faculty of Veterinary medicine, Shahid Chamran University of Ahvaz, Ahvaz, Iran 
  
 
	<sup>
	  <italic></italic>

	</sup>1. Department of Clinical sciences, Faculty of Veterinary medicine, Shahid Chamran University of Ahvaz, Ahvaz, Iran 
  
 
	<sup>
	  <italic></italic>

	</sup>Department of Basic sciences, Faculty of Veterinary medicine, Shahid Chamran University of Ahvaz, Ahvaz, Iran 
  
 
	<sup>
	  <italic></italic>

	</sup>Department of Pathobiology, Faculty of Veterinary medicine, Shahid Chamran University of Ahvaz, Ahvaz, Iran 
  
 
	</aff>
 
 
  


  <pub-date pub-type="pub">

	<day>1</day>
	<month>3</month>

	<year>2026</year>

  </pub-date>

  <volume>30</volume>

  <issue>1</issue>

  <fpage>70</fpage>

  <lpage>80</lpage>

  
			  <history>

				<date date-type="received">

				  <day>02</day>
				  <month>02</month>
				  <year>2025</year>
				</date>

			  </history>

		
			  <history>

				<date date-type="accepted">

				  <day>02</day>
				  <month>06</month>
				  <year>2025</year>
				</date>

			  </history>

		
</article-meta>

</front>



<body>

Introduction: This research evaluates the treatment benefits of platelet-rich plasma (PRP) and erythropoietin (EPO) on diabetic nephropathy and hepatopathy in rats.
Methods: Thirty male rats were separated into five groups: control, diabetic control, PRP-treated diabetic (1 mL PRP subcutaneously twice weekly), EPO-treated diabetic (300 units/kg EPO subcutaneously three times weekly), and a combination of PRP and EPO treatment (1 mL PRP twice weekly and 300 units/kg EPO three times weekly). Diabetes was induced using streptozotocin (65 mg/kg), and treatments were administered over four weeks. Serum markers for renal and hepatic function, oxidative stress indices, and histopathological changes in liver and kidney tissues were assessed.
Results: In diabetic rats, serum urea, creatinine, and liver enzymes (ALT, AST, ALP, LDH, GGT) increased significantly (p&#60;0.05), while treatment with PRP, EPO, or both significantly reduced ALT, AST, ALP, LDH, and GGT (except in the combined group for GGT; p&#62;0.05). Renal and hepatic SOD decreased significantly in diabetes (p&#60;0.05) but improved with treatment, especially in the combined group (p&#60;0.05). Renal TAC increased in diabetes and decreased significantly after treatment (p&#60;0.05). No significant changes were observed in GPX or MDA levels (p&#62;0.05). Damage in kidney and liver tissues were obtained in diabetic group. Histopathological improvements were evident, in hepatocyte integrity and glomerular structure, with EPO and PRP treatments.
Conclusion: The results emphasize the potential of EPO and PRP as complementary therapeutic strategies to reduce diabetes-induced oxidative damage and structural deterioration in liver and kidney tissues. However, further adjunctive approaches are required to achieve comprehensive organ protection.
</body>

</article>


  <article-id pub-id-type="publisher-id">2588</article-id>

  <article-categories>
	<subj-group>
	  <subject>Neurophysiology/Pharmacology</subject>

	</subj-group>
  </article-categories>

  <title-group>
	<article-title>An optimized sondell decellularization method for
sciatic nerve graft</article-title>

  </title-group>

  


  <contrib-group>

  
	<contrib contrib-type="author">

	  <name>

		<surname>Ahmadnia</surname>
		<given-names>Hananeh</given-names>
	  </name> 

	  <xref ref-type="aff">
		<sup>
		  <italic></italic>

		</sup>
	  </xref>

	</contrib> 
	

	<contrib contrib-type="author">

	  <name>

		<surname>Pashazadeh</surname>
		<given-names>Muhammad Parsa</given-names>
	  </name> 

	  <xref ref-type="aff">
		<sup>
		  <italic></italic>

		</sup>
	  </xref>

	</contrib> 
	

	<contrib contrib-type="author">

	  <name>

		<surname>Moradi</surname>
		<given-names>Ali</given-names>
	  </name> 

	  <xref ref-type="aff">
		<sup>
		  <italic></italic>

		</sup>
	  </xref>

	</contrib> 
	

	<contrib contrib-type="author">

	  <name>

		<surname>Mahdavi-Shahri</surname>
		<given-names>Naser</given-names>
	  </name> 

	  <xref ref-type="aff">
		<sup>
		  <italic></italic>

		</sup>
	  </xref>

	</contrib> 
	

	<contrib contrib-type="author">

	  <name>

		<surname>Behnam-Rassouli</surname>
		<given-names>Morteza</given-names>
	  </name> 

	  <xref ref-type="aff">
		<sup>
		  <italic></italic>

		</sup>
	  </xref>

	</contrib> 
	

	<contrib contrib-type="author">

	  <name>

		<surname>Riahi</surname>
		<given-names>Esmail</given-names>
	  </name> 

	  <xref ref-type="aff">
		<sup>
		  <italic></italic>

		</sup>
	  </xref>

	</contrib> 
	

  </contrib-group>

  
			<aff>

			
	<sup>
	  <italic></italic>

	</sup>Department of Biology, Faculty of Science, Ferdowsi University of Mashhad, Mashhad, Iran 
  
 
	<sup>
	  <italic></italic>

	</sup>Electrophysiology Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran 
  
 
	<sup>
	  <italic></italic>

	</sup>Orthopedic Research Center, Mashhad University of Medical Sciences, Mashhad, Iran 
  
 
	<sup>
	  <italic></italic>

	</sup>Department of Biology, Faculty of Science, Ferdowsi University of Mashhad, Mashhad, Iran 
  
 
	<sup>
	  <italic></italic>

	</sup>Department of Biology, Faculty of Science, Ferdowsi University of Mashhad, Mashhad, Iran 
  
 
	<sup>
	  <italic></italic>

	</sup>Electrophysiology Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran 
  
 
	</aff>
 
 
  


  <pub-date pub-type="pub">

	<day>1</day>
	<month>3</month>

	<year>2026</year>

  </pub-date>

  <volume>30</volume>

  <issue>1</issue>

  <fpage>81</fpage>

  <lpage>97</lpage>

  
			  <history>

				<date date-type="received">

				  <day>23</day>
				  <month>09</month>
				  <year>2025</year>
				</date>

			  </history>

		
			  <history>

				<date date-type="accepted">

				  <day>26</day>
				  <month>10</month>
				  <year>2025</year>
				</date>

			  </history>

		
</article-meta>

</front>



<body>

Introduction: In the realm of nerve injury repair, acellularized nerve grafts (ANGs) are gaining recognition as a promising tissue engineering approach, offering better regeneration outcomes compared to traditional nerve conduits. This study, conducted on rat and chicken sciatic nerves (R-ANGs and C-ANGs, respectively), seeks to explore an optimized nerve decellularization technique that achieves effective decellularization while preserving the extracellular matrix (ECM) integrity.
Methods: The Sondell decellularization (SD) protocol was evaluated against an optimized Sondell decellularization (OSD) method improved by DNase treatment and extra-washing with ultrapure water, and then MTT, DNA quantification, mechanical tensile, and histological evaluations were performed.
Results: Results showed that both R-ANGs and C-ANGs prepared by the OSD method had better biocompatibility, measured by MTT, than those prepared by the SD (p &#60; 0.001). DNA quantification of samples obtained from the OSD method showed an improved elimination of residual DNA fragments (p &#60; 0.0001). Mechanical tensile test also revealed a higher Young&#8217;s modulus of the OSD grafts (p &#60; 0.05). Histological studies, including hematoxylin and eosin, Masson&#8217;s trichrome, Luxol fast blue, DAPI, and scanning electron microscopy (FESEM), confirmed that the OSD was superior to the SD in preserving ECM while equally removing cell nuclei and myelinated fibers.&#160;
Conclusion: The OSD protocol yielded promising results for more reliable in vivo trials, as in vitro tests revealed better preservation of ECM components compared to the SD method. Notably, the OSD provided higher biocompatibility and improved viscoelastic integrity of the R-ANGs and C-ANGs.
</body>

</article>


  <article-id pub-id-type="publisher-id">2438</article-id>

  <article-categories>
	<subj-group>
	  <subject>Neurophysiology/Pharmacology</subject>

	</subj-group>
  </article-categories>

  <title-group>
	<article-title>The impact of adolescent fluoxetine administration
on reproductive abilities and VASA gene expression</article-title>

  </title-group>

  


  <contrib-group>

  
	<contrib contrib-type="author">

	  <name>

		<surname>Sadegzadeh</surname>
		<given-names>Farshid</given-names>
	  </name> 

	  <xref ref-type="aff">
		<sup>
		  <italic></italic>

		</sup>
	  </xref>

	</contrib> 
	

	<contrib contrib-type="author">

	  <name>

		<surname>Sakhaie</surname>
		<given-names>Nona</given-names>
	  </name> 

	  <xref ref-type="aff">
		<sup>
		  <italic></italic>

		</sup>
	  </xref>

	</contrib> 
	

	<contrib contrib-type="author">

	  <name>

		<surname>Banaei</surname>
		<given-names>Shokofeh</given-names>
	  </name> 

	  <xref ref-type="aff">
		<sup>
		  <italic></italic>

		</sup>
	  </xref>

	</contrib> 
	

	<contrib contrib-type="author">

	  <name>

		<surname>Saadati</surname>
		<given-names>Hakimeh</given-names>
	  </name> 

	  <xref ref-type="aff">
		<sup>
		  <italic></italic>

		</sup>
	  </xref>

	</contrib> 
	

  </contrib-group>

  
			<aff>

			
	<sup>
	  <italic></italic>

	</sup>Students Research Committee, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran 
  
 
	<sup>
	  <italic></italic>

	</sup>Students Research Committee, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran 
  
 
	<sup>
	  <italic></italic>

	</sup>Department of Physiology, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran 
  
 
	<sup>
	  <italic></italic>

	</sup>Pharmaceutical Sciences Research Center, Ardabil University of Medical Sciences, Ardabil, Iran 
  
 
	</aff>
 
 
  


  <pub-date pub-type="pub">

	<day>1</day>
	<month>3</month>

	<year>2026</year>

  </pub-date>

  <volume>30</volume>

  <issue>1</issue>

  <fpage>98</fpage>

  <lpage>109</lpage>

  
			  <history>

				<date date-type="received">

				  <day>09</day>
				  <month>10</month>
				  <year>2024</year>
				</date>

			  </history>

		
			  <history>

				<date date-type="accepted">

				  <day>15</day>
				  <month>07</month>
				  <year>2025</year>
				</date>

			  </history>

		
</article-meta>

</front>



<body>

Introduction: Fluoxetine (FLX) is a commonly used antidepressant drug prescribed to treat psychiatric disturbances. According to the findings of several studies, the present work is designed to assess the influences of treating FLX during adolescence on reproductive hormone levels, ovarian and testicular tissues, and VASA gene expression in both sexes.
Methods: FLX was administered (5mg/kg/day, gavage) during adolescence (on postnatal days 21-60). After the treatment duration, blood samples were collected to measure sexual hormones. Ovarian and testicular samples were taken for histological and PCR studies.
Results: Our results indicated that FLX decreased the level of progesterone in female rats, while the level of estradiol was not changed through FLX administration. The testosterone level was decreased in FLX-treated male animals. FLX also decreased the VASA gene expression in both sexes, but this effect was significant in female rats. Besides, our findings showed the potency of FLX in inducing tissue damage, degeneration of follicles, and hypospermatogenesis.
Conclusion: Therefore, treatment with FLX during adolescence leads to a decrease in reproductive activities during adolescence.
</body>

</article>


  <article-id pub-id-type="publisher-id">2478</article-id>

  <article-categories>
	<subj-group>
	  <subject>Toxicology</subject>

	</subj-group>
  </article-categories>

  <title-group>
	<article-title>Gallic acid mitigates DEHP-Induced oxidative stress
by upregulating the Nrf2-NFkB pathway in rat bone
marrow mesenchymal stem cells</article-title>

  </title-group>

  


  <contrib-group>

  
	<contrib contrib-type="author">

	  <name>

		<surname>Abnosi</surname>
		<given-names>Mohammad Husein</given-names>
	  </name> 

	  <xref ref-type="aff">
		<sup>
		  <italic></italic>

		</sup>
	  </xref>

	</contrib> 
	

	<contrib contrib-type="author">

	  <name>

		<surname>Parvaz</surname>
		<given-names>Mahrokh</given-names>
	  </name> 

	  <xref ref-type="aff">
		<sup>
		  <italic></italic>

		</sup>
	  </xref>

	</contrib> 
	

  </contrib-group>

  
			<aff>

			
	<sup>
	  <italic></italic>

	</sup>Department of Biology, Faculty of Sciences, Arak University, Arak, Iran 
  
 
	<sup>
	  <italic></italic>

	</sup>Department of Biology, Faculty of Sciences, Arak University, Arak, Iran 
  
 
	</aff>
 
 
  


  <pub-date pub-type="pub">

	<day>1</day>
	<month>3</month>

	<year>2026</year>

  </pub-date>

  <volume>30</volume>

  <issue>1</issue>

  <fpage>110</fpage>

  <lpage>124</lpage>

  
			  <history>

				<date date-type="received">

				  <day>31</day>
				  <month>01</month>
				  <year>2025</year>
				</date>

			  </history>

		
			  <history>

				<date date-type="accepted">

				  <day>19</day>
				  <month>10</month>
				  <year>2025</year>
				</date>

			  </history>

		
</article-meta>

</front>



<body>

Introduction: Di-2-ethylhexyl phthalate (DEHP), a chemical used in medical bags and tubing, can leach into the bloodstream and bone marrow, causing oxidative stress in bone marrow mesenchymal stem cells (BMSCs). This study investigates the potential of gallic acid (GA), a potent antioxidant, to counteract DEHP-induced oxidative effects in vitro.
Methods: BMSCs were exposed to various GA concentrations (0.063, 0.125, 0.25, 1, and 10 &#956;M) for 4 days, identifying 0.25 &#956;M GA as the optimal concentration based on cell viability. Cells were then treated with 100 and 500 &#956;M DEHP, with or without 0.25 &#956;M GA, for 4 or 8 days to assess viability, population doubling number, total protein levels, malondialdehyde levels, total antioxidant capacity, catalase and superoxide dismutase activity, cellular morphology, and expression of Nrf2 and NF&#954;B genes.
Results: Treatment with DEHP led to a significant, dose- and time-dependent reduction in viability, proliferation rate, total protein levels, total antioxidant capacity, and the activity of antioxidant enzymes. In contrast, GA treatment significantly increased these parameters. Additionally, DEHP resulted in an increase in malondialdehyde levels and caused morphological changes as well as down-regulated NF&#954;B and up-regulating Nrf2 expression. In the co-treatment group, GA counteracted the toxic effects of DEHP at 100 &#956;M compared with control, whereas it only partially mitigated the toxic effects at 500 &#956;M.
Conclusion: Consuming low concentrations of GA over time may reduce DEHP-induced oxidative stress. Further animal studies with GA-rich foods are essential to confirm its preventive benefits in vivo.
</body>

</article>

